Transgene Sa Stock Buy Hold or Sell Recommendation
| TRGNF Stock | USD 1.59 0.00 0.00% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Transgene SA is 'Hold'. Macroaxis provides Transgene buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding TRGNF positions.
Check out Transgene Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Transgene and provide practical buy, sell, or hold advice based on investors' constraints. Transgene SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Transgene |
Execute Transgene Buy or Sell Advice
The Transgene recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Transgene SA. Macroaxis does not own or have any residual interests in Transgene SA or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Transgene's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Transgene Trading Alerts and Improvement Suggestions
| Transgene SA generated a negative expected return over the last 90 days | |
| Transgene SA may become a speculative penny stock | |
| Transgene SA has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 9.99 M. Net Loss for the year was (19.54 M) with loss before overhead, payroll, taxes, and interest of (15.87 M). | |
| Transgene SA has accumulated about 49.57 M in cash with (31.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.5. |
Transgene Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Transgene or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Transgene's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Transgene pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.00 | |
Ir | Information ratio | 0.00 |
Transgene Volatility Alert
At this time Transgene SA exhibits very low volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Transgene's pink sheet risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Transgene's pink sheet price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Transgene Fundamentals Vs Peers
Comparing Transgene's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Transgene's direct or indirect competition across all of the common fundamentals between Transgene and the related equities. This way, we can detect undervalued stocks with similar characteristics as Transgene or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Transgene's fundamental indicators could also be used in its relative valuation, which is a method of valuing Transgene by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Transgene to competition |
| Fundamentals | Transgene | Peer Average |
| Return On Equity | -0.36 | -0.31 |
| Return On Asset | -0.16 | -0.14 |
| Profit Margin | (1.27) % | (1.27) % |
| Operating Margin | (1.39) % | (5.51) % |
| Current Valuation | 152.15 M | 16.62 B |
| Shares Outstanding | 100.2 M | 571.82 M |
| Shares Owned By Institutions | 1.70 % | 39.21 % |
| Price To Earning | (7.42) X | 28.72 X |
| Price To Book | 0.02 X | 9.51 X |
| Price To Sales | 10.71 X | 11.42 X |
| Revenue | 9.99 M | 9.43 B |
| Gross Profit | (15.87 M) | 27.38 B |
| EBITDA | (16.55 M) | 3.9 B |
| Net Income | (19.54 M) | 570.98 M |
| Cash And Equivalents | 49.57 M | 2.7 B |
| Cash Per Share | 0.50 X | 5.01 X |
| Debt To Equity | 0.25 % | 48.70 % |
| Current Ratio | 4.27 X | 2.16 X |
| Book Value Per Share | 0.55 X | 1.93 K |
| Cash Flow From Operations | (31.94 M) | 971.22 M |
| Earnings Per Share | (0.23) X | 3.12 X |
| Number Of Employees | 143 | 18.84 K |
| Beta | 0.79 | -0.15 |
| Market Capitalization | 212.74 M | 19.03 B |
| Total Asset | 101.84 M | 29.47 B |
| Retained Earnings | (500 M) | 9.33 B |
| Working Capital | 27 M | 1.48 B |
| Current Asset | 51 M | 9.34 B |
| Current Liabilities | 24 M | 7.9 B |
| Z Score | -5.6 | 8.72 |
| Net Asset | 101.84 M |
Transgene Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Transgene . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Transgene Buy or Sell Advice
When is the right time to buy or sell Transgene SA? Buying financial instruments such as Transgene Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Transgene in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Precious Metals ETFs Thematic Idea Now
Precious Metals ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Precious Metals ETFs theme has 28 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Precious Metals ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Transgene Pink Sheet
Transgene financial ratios help investors to determine whether Transgene Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Transgene with respect to the benefits of owning Transgene security.